Targeting HBP flux or enzymes regulating O-GlcNAc cycling, such as O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), holds promise for mitigating oxidative stress-related metabolic diseases. Here, OGA is linked to metabolic disease.